Nomura Holdings’s SELLAS Life Sciences SLS Stock Holding History

Nomura Holdings’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.85M	Sell	436,700 -87,000	-17%	-$389K	﹤0.01%	953
2025 Q4	$1.97M	Buy	+523,700	New	+$1.02M	﹤0.01%	1101

Other funds holding SLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Nomura Holdings's SLS Position: Q2 2021 in Review

Nomura Holdings sold out of SELLAS Life Sciences (SLS) in Q2 2021, closing a stake of 131,500 shares — an estimated $1.11M sold.

Nomura Holdings first reported a position in SLS in Q1 2021 and held it in 1 quarter. The position peaked at $1.11M in Q1 2021. 29 funds tracked by Wall St. Rank hold SLS as of Q2 2021.

Nomura Holdings reported no remaining SELLAS Life Sciences position as of Q2 2021 after selling out during the quarter.
Nomura Holdings sold 131,500 SELLAS Life Sciences shares in Q2 2021, an estimated $1.11M.
Nomura Holdings first reported a position in SELLAS Life Sciences in Q1 2021 and held it in 1 quarter.
Nomura Holdings's SELLAS Life Sciences position peaked at $1.11M in Q1 2021.
29 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2021.

Based on Nomura Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.